The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Anthony Lembo, MD: Exploring Probiotics for IBS Treatment
Lembo describes the potential of a multi-species synbiotic for the treatment of IBS based on findings from an exploratory study he presented at DDW.
Iptacopan Reduces Proteinuria, Demonstrates Benefit in C3 Glomerulopathy
In the APPEAR-C3G trial, iptacopan reduced proteinuria by 35.1% in patients with C3 glomerulopathy, with Novartis planning regulatory submissions for C3G before the end of 2024.
Vlado Perkovic, MBBS, PhD: Semaglutide's Role in CKD Based on FLOW Results
Vlado Perkovic, MBBS, PhD, discusses the results of the FLOW trial and their implications for clinical practice at ERA 24.
Brian Lacy, MD, PhD: Assessing, Treating Chronic Abdominal Bloating and Distension
Lacy reviews key considerations for the diagnostic evaluation and treatment of abdominal bloating and distension based on his session at DDW.
Elizabeth Aby, MD: Financial Burden in Adults Undergoing Liver Transplant Evaluation
Aby describes findings from a pair of studies presented at DDW exploring the prevalence and impact of financial burden in liver transplant candidates.
Prashant Singh, MD: Rethinking the Low FODMAP Diet for IBS-D
Singh explains a potential new approach to the low FODMAP diet based on findings from research he presented at DDW suggesting a simplified step-up method.
Intestinal Ultrasound’s Value for Assessing Disease Activity in IBD, with Noa Krugliak Cleveland, MD
Krugliak Cleveland explains findings from research she presented at DDW comparing intestinal ultrasound and conventional approaches to disease monitoring in IBD.
Oral JAK Inhibitors, Steroids Do Not Significantly Differ in Alopecia Hair Regrowth
A systematic review presented at AAPA 2024 showed insignificant differences in treatment outcomes between oral JAK inhibitors and oral steroids based on alopecia outcomes like SALT.
Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing
Sisson discusses the adoption of 2021 ATS / ERS guidelines, as well as the need for complementary testing and imagine to contextualize the full pulmonary patient.
Ali Rezaie, MD: Exploring a Palatable Approach to the Elemental Diet
Rezaie reviews findings from a prospective clinical trial of a novel palatable elemental diet, highlighting its 100% compliance rate and strong efficacy.
Should We Reclassify Diabetes Subtypes?
Ji Hyun “CJ” Chun, MPAS, PA-C, BC-ADM, explains the potential value of defining diabetes subtypes based on insulin, obesity and age factors.
Remo Panaccione, MD: GALAXI 2, GALAXI 3 Data for Guselkumab in Crohn’s Disease
Panaccione explains findings from GALAXI 2 and GALAXI 3 demonstrating guselkumab’s superiority to ustekinumab in Crohn’s disease, presented at DDW.
Addressing Non-Adherence in Resistant Hypertension, with Swapnil Hiremath, MD, MPH
Swapnil Hiremath, MD, MPH, discusses resistant hypertension, including using an evidence-based approach to management and addressing non-adherence.
Francisca Joly, MD, PhD: Apraglutide in Short Bowel Syndrome with Intestinal Failure
Joly explains the burden of parenteral support and the significance of new STARS data showcasing apraglutide’s potential in SBS-IF.
Primary Care Roles in Alzheimer Diagnosis, with Theresa Sivers-Teixeira, MSPA, PA-C
Sivers-Teixeira explains that while the care team should quickly expand once dementia has presented in screening, the primary care role stays consistent.
Heart Failure Treatment Outcomes and Contraindications
Ashley Malliett, DMSc, MPAS, PA-C, discusses the importance of timely diagnosis and initiated care, as well as contraindications for transplants and LVAD.
Novel Endoscopy System Feasible for Evaluation of Upper GI Diseases
A cable-transmission magnetically controlled capsule endoscopy showed comparability to conventional methods in upper GI tract examinations and lesion detection.
Getting Black Men Involved in Their Health Care, Clinical Research
Aaron Henry, PA-C, MSHS, discusses why preventive care opportunities are often missed in Black men, and how community-based interventions may help.
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Malliett discusses the signs that a caregiver should refer to an HF specialist for advanced care options, including LVAD and heart transplant.
Naim Alkhouri, MD: Interim Analysis of Phase 2 Survodutide Data Show Promise for MASH, Fibrosis
Alkhouri explains survodutide’s mechanism of action as a glucagon/GLP-1 receptor dual agonist and reviews key findings about its use in MASH from the interim analysis.
Blood-Based Test Offers Effective Screening Option for Colorectal Cancer
Data from PREEMPT CRC reveal the blood-based screening test demonstrated a 79.2% sensitivity for detecting colorectal cancer.
ESA Hyporesponders More Likely to Receive Higher Doses of Daprodustat, ESA
At the end of the study period, the median dose of daprodustat and ESA were higher among the ESA-HR cohort when compared with the non-ESA-HR group.
Clinical Quiz: AGA Recommendations on Endoscopic Eradication Therapy of Barrett’s Esophagus
A detailed overview and accompanying quiz on the recommendations made by the AGA in their 2024 guideline on endoscopic eradication
REGENERATE: Final Results for Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to NASH
End-of-study results from the phase 3 REGENERATE study were presented at DDW and highlight obeticholic acid’s trend in benefit for clinical outcomes.
GALAXI 2 & 3: Guselkumab Superior to Ustekinumab for Crohn's Disease
Both doses of guselkumab exhibited statistical superiority on all prespecified pooled endoscopic endpoints versus ustekinumab in Crohn's disease.
STARS: Apraglutide Reduces Parenteral Support in Patients with Stoma, Colon-In-Continuity
New STARS data were presented in a late-breaking abstract at DDW and build upon positive topline results for clinical responder rates and reductions in parenteral support.
Paul Feuerstadt, MD: Safety, Efficacy of Live-jslm in Patients Taking Concomitant Medications
Feuerstadt breaks down findings from an ad hoc analysis of PUNCH CD3 and what the results suggest about the use of live-jslm (Rebyota) in patients taking concomitant medications.
Depressive Symptoms Linked to Higher Risk of Peripheral Arterial Disease
During follow-up, rates of incident PAD were higher among patients with depressive symptoms compared with those without depression.
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Black men face significantly worse health outcomes in the US. Henry explains why the clinician needs to focus on building more authentic trust in their interactions.
Multitarget DNA Stool Testing Kits Could Reduce Colorectal Cancer Screening Non-Compliance
An assessment to improve colorectal screenings by shipping Cologuard kits to non-compliant patients proved beneficial for a Mayo Clinic research team.